196 related articles for article (PubMed ID: 30055770)
1. The "T" allele of apolipoprotein A5 rs2075291 is significantly associated with higher total cholesterol and triglyceride and lower high-density lipoprotein cholesterol levels in Asians: a meta-analysis.
Qian X; Li Y; Liu X; Li L; Yang K; Liu R; Zhang H; Shi Y; Yu F; Mao Z; Bie R; Wang C
Nutr Res; 2018 Aug; 56():11-22. PubMed ID: 30055770
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein A5 gene variants are associated with decreased adiponectin levels and increased arterial stiffness in subjects with low high-density lipoprotein-cholesterol levels.
Kim M; Kim M; Yoo HJ; Bang YJ; Lee SH; Lee JH
Clin Genet; 2018 Nov; 94(5):438-444. PubMed ID: 30132804
[TBL] [Abstract][Full Text] [Related]
3. The Association Between APOA5 Gene Polymorphisms and Plasma Lipids in the Turkish Cypriot Population: A Possible Biomarker for Preventing Cardiovascular Diseases.
Fahrioğlu U; Ergören MÇ
Biochem Genet; 2018 Jun; 56(3):176-187. PubMed ID: 29264753
[TBL] [Abstract][Full Text] [Related]
4. Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects.
Zhao T; Zhao J
BMC Med Genet; 2010 Aug; 11():120. PubMed ID: 20696075
[TBL] [Abstract][Full Text] [Related]
5. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
[TBL] [Abstract][Full Text] [Related]
6. Influences of APOA5 variants on plasma triglyceride levels in Uyghur population.
Li S; Hu B; Wang Y; Wu D; Jin L; Wang X
PLoS One; 2014; 9(10):e110258. PubMed ID: 25313938
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
8. Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis.
Chien KL; Hsu HC; Chen YC; Su TC; Lee YT; Chen MF
Transl Res; 2009 Sep; 154(3):133-41. PubMed ID: 19665689
[TBL] [Abstract][Full Text] [Related]
9. Association of apolipoprotein A1 and A5 polymorphisms with stroke subtypes in Han Chinese people in Taiwan.
Hsu LC; Hsu LS; Lee TH
Gene; 2019 Feb; 684():76-81. PubMed ID: 30367981
[TBL] [Abstract][Full Text] [Related]
10. The associations between proprotein convertase subtilisin/kexin type 9 E670G polymorphism and the risk of coronary artery disease and serum lipid levels: a meta-analysis.
Cai G; Zhang B; Shi G; Weng W; Ma C; Song Y; Zhang J
Lipids Health Dis; 2015 Nov; 14():149. PubMed ID: 26576960
[TBL] [Abstract][Full Text] [Related]
11. The c.553G>T Genetic Variant of the APOA5 Gene and Altered Triglyceride Levels in the Asian Population: A Meta-Analysis of Case-Control Studies.
He H; Lei L; Chen E; Dong J; Zhang K; Yang J
Genet Test Mol Biomarkers; 2016 Dec; 20(12):758-765. PubMed ID: 27813673
[TBL] [Abstract][Full Text] [Related]
12. Common variants in the genes of triglyceride and HDL-C metabolism lack association with coronary artery disease in the Pakistani subjects.
Shahid SU; Shabana NA; Cooper JA; Rehman A; Humphries SE
Lipids Health Dis; 2017 Jan; 16(1):24. PubMed ID: 28143480
[TBL] [Abstract][Full Text] [Related]
13. A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug.
Bogari NM; Aljohani A; Amin AA; Al-Allaf FA; Dannoun A; Taher MM; Elsayed A; Rednah DI; Elkhatee O; Porqueddu M; Alamanni F; Khogeer SAA; Fawzy A
BMC Cardiovasc Disord; 2019 Jan; 19(1):2. PubMed ID: 30606120
[TBL] [Abstract][Full Text] [Related]
14. Effects of APOA5 -1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysis.
Xu C; Bai R; Zhang D; Li Z; Zhu H; Lai M; Zhu Y
PLoS One; 2013; 8(2):e56216. PubMed ID: 23468858
[TBL] [Abstract][Full Text] [Related]
15. A high-carbohydrate diet enhances the adverse effect of the S2 allele of APOC3 SstI polymorphism on the TG/HDL-C ratio only in young Chinese females.
Song YY; Gong RR; Zhang Z; Li YH; Xiao LY; Zhou XD; Fang DZ
Braz J Med Biol Res; 2011 Jun; 44(6):524-30. PubMed ID: 21603779
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
[TBL] [Abstract][Full Text] [Related]
17. Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis.
Niu C; Luo Z; Yu L; Yang Y; Chen Y; Luo X; Lai F; Song Y
Lipids Health Dis; 2017 Sep; 16(1):166. PubMed ID: 28874158
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.
Yin RX; Li YY; Lai CQ
Lipids Health Dis; 2011 Aug; 10():140. PubMed ID: 21854571
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A5 gene polymorphisms are associated with non-alcoholic fatty liver disease.
Xu Y; Lu LL; Liu SS; Du SX; Zhu HL; Dong QJ; Xin YN
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):214-219. PubMed ID: 29735301
[TBL] [Abstract][Full Text] [Related]
20. The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V.
Bertoccini L; Sentinelli F; Incani M; Bailetti D; Cimini FA; Barchetta I; Cavallo MG; Cossu E; Lenzi A; Loche S; Baroni MG
Lipids Health Dis; 2017 Sep; 16(1):179. PubMed ID: 28927406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
